The Simplified Science of Corticosteroids for Clinicians.

JBJS Rev · Nov 2020 · Review

Kaplan DJ, Haskel JD, Kirby DJ, Bloom DA, Youm T

New York University Langone Medical Center, New York, NY

General Orthopaedics

SUMMARY — THE REDUCTIONThis review explains how corticosteroid solubility determines onset and duration of action, guiding selection between intra-articular (less-soluble) and extra-articular (more-soluble) formulations while noting fluorinated agents' tendon toxicity risk.
Abstract, as published

Clinicians should be aware of the differences in corticosteroid formulations as these differences dictate which agent is best in various clinical situations. Corticosteroids work primarily by modulating transcriptional, post-transcriptional, and post-translational mechanisms within cellular nuclei to decrease the production of inflammatory mediators. Because this process requires change at the cellular level, clinical effects typically take days. The main consideration when selecting a corticosteroid is solubility. Less-soluble agents have a longer onset of action and a longer duration. However, they can have negative side effects on soft-tissue structures. They are ideal for intra-articular use. More-soluble agents have a faster onset of action but are rapidly cleared. They are ideal for extra-articular soft-tissue structures. Fluorinated compounds have decreased solubility, which further increases duration of action, but they have been shown to be associated with tendon rupture and atrophy.

Featured in the 2026-09-12 issue.

← Returning to orthopaedic business as usual after COVID-19: st…Trends in Research Gap Years Among Orthopaedic Residency Appl… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.